ONXX - I've been holding my entire ONXX position, because (a) I see it as a long-term successful cancer play, especially in increasingly prosperous Asia where liver cancer is so prevalent, (b) the potential, albeit unlikely, for a Bayer buyout--they should have bought it out in the 30's, and (c) it's a hot stockpicker's market and they love growth, and ONXX is to biotech what RIMM, GOOG, and AAPL are to high tech and ISRG is to medical devices.